Related Experiment Video
Updated: Aug 29, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels
P Pennisi1, S S Signorelli, S Riccobene
1Department of Internal Medicine, University of Catania OVE, Via Plebiscito 628, 95124, Catania, Italy.
Insights
This study found a high occurrence of osteoporosis in patients with peripheral vascular disease (VD), independent of age and gender. Reduced bone formation, not increased OPG-RANKL activity, appears to drive this negative bone remodeling balance.
Area of Science:
- Endocrinology
- Orthopedics
- Cardiology
Background:
- Patients with vascular calcifications often exhibit low bone mineral density (BMD).
- The relationship between osteoporosis and peripheral vascular disease (VD) and their shared pathomechanisms remain unclear.
- Limited data exist on bone turnover markers in advanced atherosclerosis.
Purpose of the Study:
- To investigate the underlying mechanisms linking vascular and osseous disorders.
- To assess bone mineral density (BMD) and bone turnover markers in patients with severe atherosclerotic involvement.
- To explore the potential role of the OPG-RANKL system in this relationship.
Main Methods:
- Dual-energy X-ray absorptiometry (DXA) and quantitative bone ultrasound (QUS) for BMD measurement.
- Assessed serum levels of osteocalcin (OC), bone-specific alkaline phosphatase (BAP), osteoprotegerin (OPG), and RANKL.
- Measured urinary C-terminal telopeptides of type I collagen (CrossLaps) in 36 patients with advanced atherosclerosis and 30 controls.
Main Results:
- Significantly reduced BMD at the lumbar spine (63%) and proximal femur (93%) in VD patients compared to controls.
- Lower serum OC and BAP levels in VD patients, indicating reduced bone formation.
- Normal urinary CrossLaps excretion and similar serum OPG and RANKL levels between VD patients and controls.
Conclusions:
- High occurrence of osteoporosis in VD patients, independent of age and gender.
- Evidence suggests a negative bone remodeling balance due to reduced bone formation.
- The OPG-RANKL system does not appear to be significantly activated in this patient group.
Abstract:
Patients with vascular calcifications often have low bone mineral density (BMD), but it is still uncertain if osteoporosis and peripheral vascular disease (VD) are interrelated and linked by a common pathomechanism. Moreover, data on bone turnover in patients with advanced atherosclerosis are lacking. We measured BMD by dual-energy X-ray absorptiometry (DXA) and quantitative bone ultrasound (QUS), as well as the serum levels of osteocalcin (OC), bone-specific alkaline phosphatase (BAP), osteoprotegerin (OPG) and its ligand RANKL, and the urinary concentration of the C-terminal telopeptides of type I collagen (CrossLaps), in 36 patient (20 male and 16 female) with serious atherosclerotic involvement of the carotid and/or femoral artery to investigate the underlying mechanism of vascular and osseous disorders. Thirty age-matched and gender matched healthy individuals served as controls. After adjustment for age, BMD was significantly reduced at the lumbar spine in 23/36 (63%) patients (mean T score -1.71+/-1.42) and at the proximal femur in 34/36 (93%) patients (neck mean T score -2.5+/-0.88). Ten patients (27%) had abnormal QUS parameters. Gender and diabetes had no effect on the relationship between vascular calcification and bone density at any site measured. VD subjects had OC and BAP serum levels lower than controls (13.3+/-3.1 vs 27.7+/-3.3 ng/ml, P<0.01, and 8.4+/-2.3 vs 12.5+/-1.4 microg/l, P<0.01, respectively). Urinary CrossLaps excretion was not significantly different in patients with VD and in controls (257.9+/-138.9 vs 272.2+/-79.4 micro g/mmol Cr, respectively). Serum OPG and RANKL levels were similar in patients and in controls (3.5+/-1.07 vs 3.4+/-1.05 pmol/l, and 0.37+/-0.07 vs 0.36+/-0.06 pmol/l, respectively). We proved high occurrence of osteoporosis in VD, with evidence of age and gender independence. Negative bone remodelling balance would be a consequence of reduced bone formation, with no apparent increased activation of the OPG-RANKL system.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Peripheral Artery Disease I: Introduction
Bone Remodeling
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...

